# FDA Inspection 606404 - BioBancUSA - August 20, 2009

Source: https://www.keypedia.com/records/fda_inspections/biobancusa/00339749-5ee1-44c3-88b5-a22a93247399
Source feed: FDA_Inspections

> FDA Inspection 606404 for BioBancUSA on August 20, 2009. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 606404
- Company Name: BioBancUSA
- Inspection Date: 2009-08-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 738000 - 2011-07-27](https://www.keypedia.com/records/fda_inspections/biobancusa/4a9ed79c-e589-4631-8f97-9ee1e7b24d58)

Company: https://www.keypedia.com/companies/biobancusa/fed42cb2-4deb-40a8-85e4-b7cae578f1c2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d